ABBV - AbbVie posts Q4 revenue beat despite Humira patent cliff
2024-02-02 08:22:44 ET
More on AbbVie
- AbbVie Q4 Earnings Preview: Few Clouds On Horizon Thanks To Masterful Management (Rating Upgrade)
- AbbVie Inc. (ABBV) JPMorgan 42nd Annual Healthcare Conference
- AbbVie: Still Expensive Despite The Great M&A Acumen
- AbbVie reports mixed Q4 results; raises FY24 outlook
- AbbVie Q4 in focus as Humira patent cliff reaches one-year mark